NCT00472303 2019-11-04A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and MorphineGrünenthal GmbHPhase 3 Completed622 enrolled 31 charts
NCT01264887 2019-11-04Tapentadol in Chronic Malignant Tumour Related PainGrünenthal GmbHPhase 3 Terminated31 enrolled 19 charts
NCT00505414 2019-11-01A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and MorphineGrünenthal GmbHPhase 3 Terminated136 enrolled 9 charts